• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. Impact of blood glucose on cognitive function in insulin resistance: novel insights from ambulatory assessment
 
  • Details
  • Full
Options
2024
Journal Article
Title

Impact of blood glucose on cognitive function in insulin resistance: novel insights from ambulatory assessment

Abstract
Background/objectives: Insulin resistance (IR)-related disorders and cognitive impairment lead to reduced quality of life and cause a significant strain on individuals and the public health system. Thus, we investigated the effects of insulin resistance (IR), and blood glucose fluctuations on cognitive function under laboratory and free-living conditions, using ecological momentary assessment (EMA). Subjects/methods: Baseline assessments included neuropsychological tests and blood analysis. Individuals were classified as either insulin-sensitive (<2) or insulin-resistant (≥2), based on their Homeostatic Model Assessment (HOMA-IR) values. Continuous glucose monitoring (CGM) using a percutaneous sensor was performed for 1 week. Using multiple linear regression, we examined the effects of HOMA-IR and CGM metrics on cognitive domains. Working memory (WM) performance, which was assessed using EMA, 4 times a day for 3 consecutive days, was matched to short-term pre-task CGM metrics. Multilevel analysis was used to map the within-day associations of HOMA-IR, short-term CGM metrics, and WM. Results: Analyses included 110 individuals (mean age 48.7 ± 14.3 years, 59% female, n = 53 insulin-resistant). IR was associated with lower global cognitive function (b = −0.267, P = 0.027), and WM (b = −0.316; P = 0.029), but not with executive function (b = −0.216; P = 0.154) during baseline. EMA showed that higher HOMA-IR was associated with lower within-day WM performance (β = −0.20, 95% CI −0.40 to −0.00). CGM metrics were not associated with cognitive performance. Conclusions: The results confirm the association between IR and decrements in global cognitive functioning and WM, while no effects of CGM metrics were observed, making IR a crucial time point for intervention. Targeting underlying mechanisms (e.g., inflammation) in addition to glycemia could be promising to minimize adverse cognitive effects. Registered under https://drks.de/register/de identifier no. DRKS00022774. (Figure presented.)
Author(s)
Gruber, Judith R.
Universitätsklinikum Frankfurt
Ruf, Alea
Universitätsklinikum Frankfurt
Süß, Elena D.
Universitätsklinikum Frankfurt
Tariverdian, Sewin
Universitätsklinikum Frankfurt
Ahrens, Kira F.
Universitätsklinikum Frankfurt
Schiweck, Carmen
Universitätsklinikum Frankfurt
Ebner-Priemer, Ulrich Walter
Karlsruher Institut für Technologie
Edwin Thanarajah, Sharmili
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Reif, Andreas
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Matura, Silke
Universitätsklinikum Frankfurt
Journal
Nutrition and Diabetes
Funder
Horizon 2020 Framework Programme
Open Access
DOI
10.1038/s41387-024-00331-0
Additional link
Full text
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024